Dengue fever secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Although there is no commercially available vaccine for Dengue fever, it is notable that infection with one serotype is thought to produce lifelong immunity to that type, but only short term protection against the other three. Unfortunately, the risk of severe disease from secondary infection actually increases if someone previously exposed to serotype DENV-1 contracts serotype DENV-2 or DENV-3, or if someone previously exposed to DENV-3 acquires DENV-2.^[1]

References

↑ Guzmán MG, Alvarez M, Rodríguez R, Rosario D, Vázquez S, Vald s L; et al. (1999). “Fatal dengue hemorrhagic fever in Cuba, 1997”. Int J Infect Dis. 3 (3): 130–5. PMID 10460923.

[pmid10460923-1] Guzmán MG, Alvarez M, Rodríguez R, Rosario D, Vázquez S, Vald s L; et al. (1999). “Fatal dengue hemorrhagic fever in Cuba, 1997”. Int J Infect Dis. 3 (3): 130–5. PMID 10460923.

[1]